Literature DB >> 22848000

Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age.

Jean M Mulcahy Levy1, Tiffany Tello, Roger Giller, Greta Wilkening, Ralph Quinones, Amy K Keating, Arthur K Liu.   

Abstract

BACKGROUND: Total body irradiation (TBI) is an important component of hematopoietic stem cell transplant (SCT) for pediatric malignancies. With increasing survival rates, late effects of SCT become more important. Younger children may be at particular risk of late effects of radiation and SCT.
METHODS: We retrospectively reviewed outcomes of children less than 3 years of age who received TBI as part of their preparative regimen for SCT at Children's Hospital Colorado. Clinical information including the date of last follow-up, most recent lab values, and physiologic tests were extracted from the medical record.
RESULTS: Of 81 patients who underwent SCT, 19 received TBI and of those, 15 were long-term survivors available for review. Late effects occurring in greater than 50% of the children included abnormalities involving endocrine, metabolic, renal, cataracts, and neurocognitive systems. Other organs involved less commonly included liver, skeletal, and cardiac abnormalities. Solid tumors were a rare finding with only one patient developing a benign osteochondroma and no identified secondary malignancies.
CONCLUSIONS: TBI has been shown to be an important part of the preparative regimen for patients undergoing SCT. Our results, similar to other studies, suggest TBI in patients less than 3 years of age will likely result in multi-organ dysfunction including endocrine, metabolic, renal, eye, and neurocognitive abnormalities. A longitudinal study with standardized testing of these systems would further clarify the late effects concerns in this patient population.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22848000      PMCID: PMC3488362          DOI: 10.1002/pbc.24252

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  24 in total

1.  Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters.

Authors:  M L van Kempen-Harteveld; H Struikmans; H B Kal; I van der Tweel; M P Mourits; L F Verdonck; J Schipper; J J Battermann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

Authors:  S M Davies; N K Ramsay; J P Klein; D J Weisdorf; B Bolwell; J Y Cahn; B M Camitta; R P Gale; S Giralt; C Heilmann; P J Henslee-Downey; R H Herzig; R Hutchinson; A Keating; H M Lazarus; G A Milone; S Neudorf; W S Perez; R L Powles; H G Prentice; G Schiller; G Socié; M Vowels; J Wiley; A Yeager; M M Horowitz
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 3.  Endocrine complications of hematopoietic stem cell transplantation.

Authors:  Wassim Chemaitilly; Charles A Sklar
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

4.  Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.

Authors:  Eric J Chow; Jill H Simmons; Christian L Roth; K Scott Baker; Paul A Hoffmeister; Jean E Sanders; Debra L Friedman
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-01       Impact factor: 5.742

5.  Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood.

Authors:  M Taskinen; U M Saarinen-Pihkala; L Hovi; M Lipsanen-Nyman
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

6.  Late effects in survivors of infant leukemia.

Authors:  W Leung; M Hudson; Y Zhu; G K Rivera; R C Ribeiro; J T Sandlund; L C Bowman; W E Evans; L Kun; C H Pui
Journal:  Leukemia       Date:  2000-07       Impact factor: 11.528

Review 7.  The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.

Authors:  K Scott Baker; Dorine Bresters; Jane E Sande
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

8.  Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

Authors:  Joanna L Perkins; Alicia S Kunin-Batson; Nancy M Youngren; Kirsten K Ness; Kami J Ulrich; Melissa J Hansen; Anna Petryk; Julia Steinberger; Fiona S Anderson; K Scott Baker
Journal:  Pediatr Blood Cancer       Date:  2007-12       Impact factor: 3.167

9.  Cognitive and academic consequences of stem-cell transplantation in children.

Authors:  Sean Phipps; Shesh N Rai; Wing-Hang Leung; Shelly Lensing; Maggi Dunavant
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

10.  Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness.

Authors:  Robert D Murray; Gilbert Wieringa; Jeremy A Lawrance; Judith E Adams; Stephen M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

View more
  24 in total

1.  Osteochondroma in long-term survivors of high-risk neuroblastoma.

Authors:  Brian H Kushner; Stephen S Roberts; Danielle N Friedman; Deborah Kuk; Irina Ostrovnaya; Shakeel Modak; Kim Kramer; Ellen M Basu; Nai-Kong V Cheung
Journal:  Cancer       Date:  2015-02-27       Impact factor: 6.860

2.  Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation.

Authors:  Radojka M Savic; Morton J Cowan; Christopher C Dvorak; Sung-Yun Pai; Luis Pereira; Imke H Bartelink; Jaap J Boelens; Robbert G M Bredius; Rob F Wynn; Geoff D E Cuvelier; Peter J Shaw; Mary A Slatter; Janel Long-Boyle
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-09       Impact factor: 5.742

3.  Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.

Authors:  Danielle Novetsky Friedman; Patrick Hilden; Chaya S Moskowitz; Maya Suzuki; Farid Boulad; Nancy A Kernan; Suzanne L Wolden; Kevin C Oeffinger; Charles A Sklar
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-28       Impact factor: 5.742

4.  Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Kendra R Parris; Kathryn M Russell; Brandon M Triplett; Sean Phipps
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

5.  Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation.

Authors:  Victoria W Willard; Wing Leung; Qinlei Huang; Hui Zhang; Sean Phipps
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

6.  Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.

Authors:  Lynda M Vrooman; Heather R Millard; Ruta Brazauskas; Navneet S Majhail; Minoo Battiwalla; Mary E Flowers; Bipin N Savani; Görgün Akpek; Mahmoud Aljurf; Rajinder Bajwa; K Scott Baker; Amer Beitinjaneh; Menachem Bitan; David Buchbinder; Eric Chow; Christopher Dandoy; Andrew C Dietz; Lisa Diller; Robert Peter Gale; Shahrukh K Hashmi; Robert J Hayashi; Peiman Hematti; Rammurti T Kamble; Kimberly A Kasow; Morris Kletzel; Hillard M Lazarus; Adriana K Malone; David I Marks; Tracey A O'Brien; Richard F Olsson; Olle Ringden; Sachiko Seo; Amir Steinberg; Lolie C Yu; Anne Warwick; Bronwen Shaw; Christine Duncan
Journal:  Biol Blood Marrow Transplant       Date:  2017-04-28       Impact factor: 5.742

Review 7.  Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia.

Authors:  Anita Lawitschka; Christina Peters
Journal:  Curr Oncol Rep       Date:  2018-08-03       Impact factor: 5.075

8.  Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.

Authors:  Kristin M Page; Myriam Labopin; Annalisa Ruggeri; Gerard Michel; Cristina Diaz de Heredia; Tracey O'Brien; Alessandra Picardi; Mouhab Ayas; Henrique Bittencourt; Ajay J Vora; Jesse Troy; Carmen Bonfim; Fernanda Volt; Eliane Gluckman; Peter Bader; Joanne Kurtzberg; Vanderson Rocha
Journal:  Biol Blood Marrow Transplant       Date:  2017-04-21       Impact factor: 5.742

9.  TLI in pediatric patients.

Authors:  A Ocanto; A Escribano; L Glaría; I Rodríguez; C Ferrer; C Huertas; A Pérez; R Morera
Journal:  Clin Transl Oncol       Date:  2019-09-21       Impact factor: 3.405

10.  Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.

Authors:  D Bresters; A Lawitschka; C Cugno; U Pötschger; A Dalissier; G Michel; K Vettenranta; M Sundin; A Al-Seraihy; M Faraci; P Sedlacek; A B Versluys; A Jenkins; P Lutz; B Gibson; A Leiper; M A Diaz; P J Shaw; R Skinner; T A O'Brien; N Salooja; P Bader; C Peters
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.